How Analysts Feel About Nektar Therapeutics (NKTR) After Achieving 52-Week High?

Nektar Therapeutics

Nektar Therapeutics

Ny State Common Retirement Fund invested in 0.01% or 277,184 shares. Credit Suisse Ag reported 0.01% in Nektar Therapeutics (NASDAQ:NKTR). The stock presently has a consensus rating of "Buy" and an average target price of $31.82.

On November 9, 2017 Canaccord Genuity released research on NKTR by announcing an initial rating of "Buy".

Nektar Therapeutics on 9/29/2017 reported its EPS as $-0.28 with the analysts projecting the EPS of the stock as $-0.26. Prelude Capital Management Ltd Limited Liability Company reported 0.08% stake. They issued an "outperform" rating for the company. Finally, BidaskClub lowered Nektar Therapeutics from a "buy" rating to a "hold" rating in a research report on Friday, August 4th. The stock has a current ATR of 1.44.

More news: Very Illuminating Messages Between WikiLeaks and Don Jr
More news: Hitman TV Series in the Works at Hulu from John Wick Creator
More news: Trump Asks Chinese President to Help Resolve LiAngelo Ball's Shoplifting Thing

Currently, the analyst consensus on Nektar Therapeutics is Strong Buy and the average price target is $34.17, representing a 5.1% upside.

Analysts expect Nektar Therapeutics (NASDAQ:NKTR) to report $-0.34 EPS on March, 7.They anticipate $0.06 EPS change or 21.43 % from last quarter's $-0.28 EPS. Nektar Therapeutics has a fifty-two week low of $11.41 and a fifty-two week high of $33.67. For NKTR, the company now has $37.97 Million of cash on the books, which is offset by $2.48 Million current liabilities. Mizuho began coverage on shares of Nektar Therapeutics in a research report on Tuesday, September 26th. The biopharmaceutical company reported $0.37 earnings per share for the quarter, topping the consensus estimate of $0.21 by $0.16. Nektar Therapeutics had a negative return on equity of 8,769.15% and a negative net margin of 98.87%.

Nektar Therapeutics (NASDAQ:NKTR) last issued its quarterly earnings data on Tuesday, November 7th. During the same quarter in the prior year, the firm earned ($0.32) earnings per share. Along with these its last twelve month performance is stands at 137.57% while moved 64.06% for the past six months. If you are reading this piece of content on another website, it was illegally copied and republished in violation of United States and global trademark & copyright law. Shares for $33,255 were sold by Doberstein Stephen K. The insider Labrucherie Gil M sold $62,149. The shares were sold at an average price of $19.32, for a total transaction of $32,863.32. Following the sale, the chief executive officer now owns 122,908 shares in the company, valued at $1,705,963.04. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. On Wednesday, August 26 the stock rating was downgraded by TheStreet to "Hold". Insiders sold a total of 1,024,757 shares of company stock valued at $25,974,361 in the last ninety days. The disclosure for this purchase can be found here. Arizona State Retirement System now owns 80,945 shares of the biopharmaceutical company's stock valued at $1,582,000 after buying an additional 800 shares in the last quarter. Bank of New York Mellon Corp boosted its stake in Nektar Therapeutics by 0.6% during the 2nd quarter. Wells Fargo & Company MN lifted its position in shares of Nektar Therapeutics by 5.0% during the 3rd quarter. The company's past year sales total was 37450. 5,603 were reported by Zurcher Kantonalbank (Zurich Cantonalbank). Following the completion of the transaction, the senior vice president now owns 52,016 shares of the company's stock, valued at $1,508,464. Zurcher Kantonalbank Zurich Cantonalbank now owns 5,603 shares of the biopharmaceutical company's stock valued at $110,000 after acquiring an additional 692 shares during the last quarter. Genesee Valley Trust Co. now owns 12,189 shares of the biopharmaceutical company's stock valued at $209,000 after buying an additional 54 shares during the last quarter. Hedge funds and other institutional investors own 85.85% of the company's stock. BlackRock Inc. raised its stake in shares of Nektar Therapeutics by 0.9% in the second quarter. The Company is engaged in the development of a pipeline of drug candidates that utilize its PEGylation and advanced polymer conjugate technology platforms, which are created to enable the development of new molecular entities that target known mechanisms of action.

Recommended News

  • RT Says It Has Registered as Foreign Agent

    RT Says It Has Registered as Foreign Agent

    Moscow has repeatedly denied the allegations of election meddling and said it views the actions against RT as an unfriendly act. The embassy warned restrictions on the activities of Russian media "would inevitably entail immediate and reciprocal measures".

    Shell sells £1.3bn stake in Australia's Woodside Petroleum

    The sale of the shares, which represent 13.28% of the issued capital of Woodside, is expected to be complete on November 14. The company said that represented 64% of its interest in Woodside and 8.5% of the issued capital in Woodside.
    Government confirms new bill to cover Brexit withdrawal, transition

    Government confirms new bill to cover Brexit withdrawal, transition

    Davis, along with Prime Minister Theresa May and most of the Conservative party's cabal of Brexiteers have resisted allowing such a final such Act of Parliament.
  • Turkey-Russia solidarity in settling regional crises strengthens their ties: Erdogan

    Turkey-Russia solidarity in settling regional crises strengthens their ties: Erdogan

    The weapon can not be integrated into North Atlantic Treaty Organisation defenses. Turkey has been annoyed by both Russian and USA missions in Syria.
    Hospitals treat victims of IN  nightclub shooting

    Hospitals treat victims of IN nightclub shooting

    Police would not reveal any further details about the circumstances of the shooting or a possible motive for the gunmen. Four male and three female victims were found in the club in the northern in city located near Chicago, AP reported.
    Shinzo Abe tumbles into bunker while golfing with Donald Trump

    Shinzo Abe tumbles into bunker while golfing with Donald Trump

    Abe told reporters about the agreement just after meeting with Putin in the Vietnamese coastal city of Danang. The leaders are also expected to unite in condemning North Korea's nuclear and ballistic missile tests.
  • Packers RB Jones to miss several weeks with knee injury

    Packers RB Jones to miss several weeks with knee injury

    Jamaal Williams and Devante Mays are the other options if the coaching staff wants to divide the workload. The Packers believe Ty Montgomery (ribs) has a "chance" to play in Week 11 against the Ravens.
    Jacqui Lambie Could Resign Within 24 Hours Over Possible Dual Citizenship

    Jacqui Lambie Could Resign Within 24 Hours Over Possible Dual Citizenship

    It is not the first time Senator Lambie has been affected by the Constitution of Australia's dual-citizenship rules. However she is awaiting confirmation from British Authorities.
    Nathaniel Clyne ruled out until February

    Nathaniel Clyne ruled out until February

    The Liverpool manager said: "He was in a good way, running with high intensity but the muscle showed a little reaction". Speaking on November 3, the German said: "He [Clyne] was in a good way and then had a little setback".
  • Antibiotic awareness week celebrated

    Antibiotic awareness week celebrated

    World Antibiotic Awareness Week is being observed from November 13 to 19, under the theme "Antibiotic, the End of an Era". For example, antibiotic-resistant gonorrhoea has now become nothing short of a major health crisis.
    Penn State Frat Death

    Penn State Frat Death

    Authorities will be releasing new information into the hazing death at Penn State during a news conference this afternoon. CBS News reports that there are new charges in the death of a 19-year-old fraternity pledge at Penn State University.

    Missouri Attorney General to investigate Google

    Hawley - a Republican who is running for the GOP Senate nomination to challenge sitting Democratic Sen. Hawley said that to his knowledge, no other states have opened comparable investigations into Google.

We are pleased to provide this opportunity to share information, experiences and observations about what's in the news.
Some of the comments may be reprinted elsewhere in the site or in the newspaper.
Thank you for taking the time to offer your thoughts.